Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine + midazolam versus ketamine alone versus morphine for acute pain in the emergency department
IRCT20171106037280N2Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ketamine, midazolam and morphine in acute pain (3 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Pain level reduction at 90 minutes and Adverse reactions. Started Nov 2017; status: completed.
02
Drugs
ketaminemidazolammorphine
03
Conditions
acute pain
Beyond the preview
Go deeper on IRCT20171106037280N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171106037280N2.